Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia

Clinical trial NCT01829711 · COMPLETED

Trial details

NCT number: NCT01829711
Sponsor: MedImmune LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Leukemia, Hairy Cell

Start date: 2013-04-29
Primary completion: 2017-05-24
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.